Epitome Residency Private Limited, a under cirp private limited company, was established on 03 July 2008 in Mumbai, Maharashtra, India. Engaging in real estate builders & developers within the construction sector, it holds CIN: U45100MH2008PTC184241. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹3.75 Cr and a paid-up capital of ₹0.14 M.
Formerly known as Epitome Realty Projects Private Limited, Wadhwa Power Private Limited. It upholds a compliant status. Employing 34 professional, Its leadership includes Sanjay Rajkumar Chhabria (Director), Anil Nandlal Chhabria (Director), Bharat Ramakant Upadhyay (Irp/Rp/Liquidator). Past directors included Vijay Vasudev Wadhwa, Sanjay Rajkumar Chhabria, Anil Nandlal Chhabria. It holds ₹147.00 Cr open charges and ₹700.36 Cr settled loans. Its latest AGM occurred on 30 December 2020, with the balance sheet filed on 31 March 2020. It is based at One Bkc, A Wing 1401, Plot No. C-66, G Block, Bandra Kurla Complex, Bandra (E, Ast),, Mumbai, Maharashtra, 400051.
U45100MH2008PTC184241
184241
03 July 2008
₹3.75 Cr
₹0.14 M
Roc Mumbai
Unlisted
Under Cirp
Explore comprehensive insights into Epitome Residency Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Sanjay Rajkumar Chhabria | Director | 31 Mar 2017 | Current |
| Anil Nandlal Chhabria | Director | 31 Mar 2017 | Current |
| Bharat Ramakant Upadhyay | Irp/Rp/Liquidator | 29 May 2025 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 31 Mar 2017 | Past |
| Pramod Abcsdd | Director | 23 Jul 2014 | Past |
| Pramod Abcsdd | Additional Director | 28 Sep 2017 | Past |
| Pramod Abcsdd | Irp/Rp/Liquidator | 11 May 2024 | Past |
| Pramod Abcsdd | Director | 31 Mar 2017 | Past |
| Pramod Abcsdd | Additional Director | 14 Oct 2019 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Epitome Residency Private Limited, for the financial year ended 2019, experienced significant reduction in revenue, with a 68.25% decrease. The company also saw a substantial fall in profitability, with a 31.52% decrease in profit. The company's net worth observed a substantial decline by a decrease of 123.77%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2019, Epitome Residency had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹1,470,000,000.00
₹7,003,606,356.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 11 Sep 2017 | Others | ₹45.00 Cr | Open |
| 13 Apr 2017 | Others | ₹45.00 Cr | Open |
| 13 Apr 2017 | Others | ₹57.00 Cr | Open |
| 16 Sep 2019 | Others | ₹288.86 Cr | Satisfied |
| 16 Sep 2019 | Others | ₹267.00 Cr | Satisfied |
Explore comprehensive loan charge details -
Epitome Residency has a workforce of 34 employees as of Apr 02, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Epitome Residency, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Epitome Residency's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Bharat Ramakant Upadhyay was appointed as a IRP/RP/Liquidator was appointed as a IRP/RP/Liquidator on 29 May 2025 & has been associated with this company since 6 months . was documented.
The activity A charge registered on 16 Sep 2019 via Charge ID 100291615 with Others was fully satisfied on 25 Apr 2021. was completed.
The activity A charge registered on 16 Sep 2019 via Charge ID 100291611 with Others was fully satisfied on 25 Apr 2021. was completed.
The activity Epitome Residency Private Limited last Annual general meeting of members was held on 30 Dec 2020 as per latest MCA records. was completed.
Epitome Residency Private Limited has filed its annual Financial statements for the year ended 31 Mar 2020 with Roc Mumbai. was recorded as a recent event.
The activity A charge with Others amounted to Rs. 288.86 Cr with Charge ID 100291615 was registered on 16 Sep 2019. was completed.
When you try to buy discounted real estate debt but no one else wants it so you win by default..
A Radius Group spokesperson had earlier told ET that the company will be paying the interest component of Rs 30 crore to Yes Bank on July 5..
While Radius has confirmed the deal with Blackstone, it refused to divulge details including valuation.
When you thought South Mumbai property market couldn't get any more expensive, Radius Developers bought Ram Mansion for over Rs 235 crore from Peninsula Land. The bungalow will be turned into a luxury high-rise apartment block with a total development potential of 50,000 sq ft. This is one of the biggest bungalow deals in South Mumbai after three years. Looks like the billionaires' district just got a little more crowded..
The CIN of Epitome Residency Private Limited is U45100MH2008PTC184241.
Epitome Residency Private Limited is headquartered at One Bkc, A Wing 1401, Plot No. C-66, G Block, Bandra Kurla Complex, Bandra (E, Ast),, Mumbai, Maharashtra, 400051.
Epitome Residency Private Limited was incorporated on 03 July 2008.
The current directors of Epitome Residency Private Limited are
The primary industry of Epitome Residency Private Limited is Construction.
Epitome Residency Private Limited is unlisted.
The authorized capital of Epitome Residency Private Limited is ₹3.75 Cr, and the paid-up capital is ₹0.14 M.
The compliance status of Epitome Residency Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX